Riskpilot← Back to searchSign inGet full accessMunhälsan Sandviken AB
ABActiveOrg 5566847405Plangatan 4 CDental practice care activities · NACE 8623Est. 20053 employees
Revenue 2025
SEK 3,5M
+3% vs 2024
EBITDA margin
9.0%
+24% vs 2024
Equity ratio
58.6%
Financial strength
Net profit 2025
SEK 224K
+27% vs 2024
| Revenue | SEK 3,5M | +3% |
| EBITDA | SEK 319K | +24% |
| Net profit | SEK 224K | +27% |
| Total assets | SEK 1,3M | +11% |
| Equity | SEK 769K | +19% |
| Employees | 3 | — |
Legal name
Munhälsan Sandviken AB
Org number
5566847405
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
23 augusti 2005
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Lindfors, Sara Helena Sand, Eva Marie
Company purpose
Bolaget skall bedriva tandvård och tandhygienistvård och därmed förenlig verksamhet.
Address
Plangatan 4 C
Email
marie@munhalsanab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 040 | 3 161 | 3 282 | 3 435 | 3 534 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 266 | 134 | 231 | 258 | 319 |
| Depreciation & amort. | −154 | −44 | −41 | −45 | −39 |
| EBIT | 112 | 90 | 190 | 213 | 280 |
| Net financials | −7 | −3 | — | 17 | 5 |
| Profit before tax | 146 | 182 | 206 | 230 | 288 |
| Tax | −36 | −42 | −59 | −53 | −64 |
| Net profit | 110 | 140 | 147 | 177 | 224 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 133 | 986 | 1 099 | 1 182 | 1 313 |
| Equity | 382 | 421 | 568 | 645 | 769 |
| Long-term debt | 140 | 0 | 0 | 0 | 0 |
| Short-term debt | 431 | 480 | 462 | 468 | 478 |
| Total debt | 571 | 480 | 462 | 468 | 478 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20212025
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20212025
Net profit margin
6.3%
This company
8.1%
Market median
-22% vs market
20212025
Asset turnover
2.69×
This company
1.12×
Market median
+140% vs market
20212025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Chief Auditor | Chief Auditor | 2026 |
| Former (1) | ||
JT Audit | Audit | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Munhälsan Sandviken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Thomas Holmgren | Audit | 0 companies |
| Elisabeth Anna Sofia Back | Chief Auditor | 0 companies |
| Stig J:son Sand | Deputy Board Member | 0 companies |
| Eva Marie Sand | Chairman | 0 companies |
| Sara Helena Lindfors | Board of Directors | 0 companies |